The interplay between cognition, depression, anxiety, and sleep in primary Sjogren's syndrome patients.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
01 08 2022
01 08 2022
Historique:
received:
15
11
2021
accepted:
25
07
2022
entrez:
1
8
2022
pubmed:
2
8
2022
medline:
4
8
2022
Statut:
epublish
Résumé
Primary Sjögren's syndrome (pSS) is an autoimmune disease with frequent neurological involvement. Memory complaints are common, but their precise patterns remain unclear. We wanted to characterize patterns of neurocognitive profiles in pSS patients with cognitive complaints. Only pSS patients with memory complaints were included, prospectively. Cognitive profiles were compiled through a comprehensive cognitive evaluation by neuropsychologists. Evaluations of anxiety, depression, fatigue, sleep disorders and quality of life were performed for testing their interactions with cognitive profiles. All 32 pSS patients showed at least borderline cognitive impairment, and 17 (53%) exhibited a pathological cognitive profile: a hippocampal profile (37%), a dysexecutive profile (22%), and an instrumental profile (16%) (possible overlap). Regarding the secondary objectives: 37% of patients were depressed, and 48% exhibited a mild-to-severe anxiety trait. Sleep disorders were frequent (excessive daytime sleepiness (55%), high risk for sleep apnea (45%), and insomnia (77%)). Cognitive impairments could not be explained alone by anxiety, depression or sleep disorders. Fatigue level was strongly associated with sleep disorders. Our study highlights that cognitive complaints in pSS patients are supported by measurable cognitive impairments, apart from frequently associated disorders such as depression, anxiety or sleep troubles. Sleep disorders should be screened.
Identifiants
pubmed: 35915312
doi: 10.1038/s41598-022-17354-1
pii: 10.1038/s41598-022-17354-1
pmc: PMC9343365
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
13176Informations de copyright
© 2022. The Author(s).
Références
Maciel, G. et al. Hospitalisation rates among patients with primary Sjögren’s syndrome: a population-based study, 1995–2016. RMD Open 4, e000575 (2018).
pubmed: 29531781
pmcid: 5845402
doi: 10.1136/rmdopen-2017-000575
Manzo, C., Martinez-Suarez, E., Kechida, M., Isetta, M. & Serra-Mestres, J. Cognitive function in primary Sjögren’s syndrome: A systematic review. Brain Sci. 9, 85 (2019).
pmcid: 6523842
doi: 10.3390/brainsci9040085
Delalande, S. et al. Neurologic manifestations in primary Sjögren syndrome: A study of 82 patients. Medicine (Baltimore) 83, 280–291 (2004).
doi: 10.1097/01.md.0000141099.53742.16
Morreale, M. et al. Neurological involvement in primary Sjögren syndrome: A focus on central nervous system. PLoS ONE 9, e84605 (2014).
pubmed: 24465419
pmcid: 3896357
doi: 10.1371/journal.pone.0084605
Blanc, F. et al. Cognitive dysfunction and dementia in primary Sjögren’s syndrome. ISRN Neurol. 2013, 501327 (2013).
pubmed: 24224097
pmcid: 3793286
doi: 10.1155/2013/501327
Koçer, B. et al. Cognition, depression, fatigue, and quality of life in primary Sjögren’s syndrome: Correlations. Brain Behav. 6, e00586 (2016).
pubmed: 28032007
pmcid: 5167008
doi: 10.1002/brb3.586
Faurholt-Jepsen, M. et al. Patient-evaluated cognitive function measured with smartphones and the association with objective cognitive function, perceived stress, quality of life and function capacity in patients with bipolar disorder. Int. J. Bipolar Disord. 8, 31 (2020).
pubmed: 33123812
pmcid: 7596112
doi: 10.1186/s40345-020-00205-1
Gairy, K., Knight, C., Anthony, P. & Hoskin, B. Burden of illness among subgroups of patients with primary Sjögren’s syndrome and systemic involvement. Rheumatology (Oxford) https://doi.org/10.1093/rheumatology/keaa508 (2020).
doi: 10.1093/rheumatology/keaa508
Riega-Torres, J. C. L. et al. Cognitive dysfunction in Sjögren’s syndrome using the montreal cognitive assessment questionnaire and the automated neuropsychological assessment metrics: A cross-sectional study. Int. J. Rheum. Dis. 23, 1019–1023 (2020).
pubmed: 32608054
doi: 10.1111/1756-185X.13889
Tezcan, M. E. et al. Primary Sjögren’s syndrome is associated with significant cognitive dysfunction. Int. J. Rheum. Dis. 19, 981–988 (2016).
pubmed: 27455357
doi: 10.1111/1756-185X.12912
Albrecht, K. et al. Comorbidity and health care utilisation in persons with Sjögren’s syndrome: A claims data analysis. Clin. Exp. Rheumatol. 38(Suppl 126), 78–84 (2020).
pubmed: 33025885
Yeh, T.-C. et al. Risk of obstructive sleep apnea in patients with Sjögren syndrome and Behçet’s disease: A nationwide, population-based cohort study. Sleep Breath. 24, 1199–1205 (2020).
pubmed: 31900884
doi: 10.1007/s11325-019-01953-w
Shiboski, C. H. et al. 2016 American college of rheumatology/European league against rheumatism classification criteria for primary Sjögren’s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Ann. Rheum. Dis. 76, 9–16 (2017).
pubmed: 27789466
doi: 10.1136/annrheumdis-2016-210571
Seror, R. et al. Validation of EULAR primary Sjögren’s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann. Rheum. Dis. 74, 859–866 (2015).
pubmed: 24442883
doi: 10.1136/annrheumdis-2013-204615
Poitrenaud, J., Eustache, F. & Agniel, A. Neuropsychologie Clinique des Démences : Evaluations et Prise en Charge (Solal, 1995).
Thomas-Anterion, C., Honore-Masson, S., Berne, G., Ruel, J. & Laurent, B. Le questionnaire de plainte cognitive (QPC) : Un outil de recherche de plainte suspecte d’évoquer une maladie d’Alzheimer. In L’année gérontologique, pp. 56–65 (2003).
Folstein, M. F., Folstein, S. E. & McHugh, P. R. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189–198 (1975).
pubmed: 1202204
doi: 10.1016/0022-3956(75)90026-6
Van der Linden, M. et al. L’épreuve de rappel libre/rappel indicé à 16 items (RL/RI-16). in Vol. L’évaluation des Troubles de la Mémoire. Présentation de Quatre Tests de Mémoire Episodique (Avec Leur Etalonnage) (Marseille : Solal, 2004).
Wechsler, D. Wechsler Adults Intelligence Scale WAIS-III (Editions du Centre de Psychologie Appliquée, 2000).
Tombaugh, T. Trail making test A and B: Normative data stratified by age and education. Arch. Clin. Neuropsychol. 19, 203–214 (2004).
pubmed: 15010086
doi: 10.1016/S0887-6177(03)00039-8
Berry, D., Allen, R. & Schmitt, F. Rey-Osterrieth complex figure: Psychometric characteristics in a geriatric sample. Clin. Neuropsychol. 5(2), 143–153 (1991).
doi: 10.1080/13854049108403298
Cardebat, D., Doyon, B., Puel, M., Goulet, P. & Joanette, Y. Formal and semantic lexical evocation in normal subjects performance and dynamics of production as a function of sex, age and educational level. Acta Neurol. Belg. 90, 207–217 (1990).
pubmed: 2124031
Stroop, J. Studies of interference in serial verbal reactions. J. Exp. Psychol. 18(6), 643–662 (1935).
doi: 10.1037/h0054651
Warrington, E. K. & Merle, J. The Visual Object and Space Perception Battery (Thames Valley Test Company, 1991).
Deloche, G. & Hannequin, D. Test de Dénomination Orale D’images. (les Editions du Centre de Psychologie Appliquée).
Peigneux, P. et al. A neuropsychological and functional brain imaging study of visuo-imitative apraxia. Rev. Neurol. (Paris) 156, 459–472 (2000).
Chalder, T. et al. Development of a fatigue scale. J. Psychosom. Res. 37, 147–153 (1993).
pubmed: 8463991
doi: 10.1016/0022-3999(93)90081-P
Schwarz, R., Krauss, O. & Hinz, A. Fatigue in the general population. Onkologie 26, 140–144 (2003).
pubmed: 12771522
Netzer, N. C., Stoohs, R. A., Netzer, C. M., Clark, K. & Strohl, K. P. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann. Intern. Med. 131, 485–491 (1999).
pubmed: 10507956
doi: 10.7326/0003-4819-131-7-199910050-00002
Johns, M. W. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 14, 540–545 (1991).
pubmed: 1798888
doi: 10.1093/sleep/14.6.540
Bastien, C. H., Vallières, A. & Morin, C. M. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2, 297–307 (2001).
pubmed: 11438246
doi: 10.1016/S1389-9457(00)00065-4
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J. & Erbaugh, J. An inventory for measuring depression. Arch. Gen. Psychiatr. 4, 561–571 (1961).
pubmed: 13688369
doi: 10.1001/archpsyc.1961.01710120031004
Kosmadakis, C. S., Bungener, C., Pierson, A., Jouvent, R. & Widlöcher, D. Translation and validation of the revised social anhedonia scale (SAS Social Anhedonia Scale, M.L. Eckblad, L.J. Chapman et al., 1982). Study of the internal and concurrent validity in 126 normal subjects. Encephale 21, 437–443 (1995).
pubmed: 8674468
Gray-Little, B., Williams, V. & Hancock, T. An itemresponse theory analysis of the Rosenberg self-esteem scale. Personal. Soc. Psychol. Bull. 23(5), 443–451 (1997).
doi: 10.1177/0146167297235001
Spielberger, C. D. State-Trait Anxiety Inventory for Adults Sampler Set: Manual, Instrument and Scoring Guide (Mind Garden Inc, 1983).
Seeliger, T. et al. Cognitive impairment in patients with Neuro-Sjögren. Ann. Clin. Transl. Neurol. https://doi.org/10.1002/acn3.51123 (2020).
doi: 10.1002/acn3.51123
pubmed: 32628345
pmcid: 7448149
Yoshikawa, K. et al. Prevalence of Sjögren’s syndrome with dementia in a memory clinic. J. Neurol. Sci. 322, 217–221 (2012).
pubmed: 22901967
doi: 10.1016/j.jns.2012.07.060
Liliang, P.-C. et al. Population-based study suggests an increased risk of Alzheimer’sdisease in Sjögren’s syndrome. Clin. Rheumatol. 37, 935–941 (2018).
pubmed: 29243055
doi: 10.1007/s10067-017-3940-y
Lin, T.-M. et al. Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: A nationwide cohort study. PLoS ONE 13, e0186475 (2018).
pubmed: 29304089
pmcid: 5755737
doi: 10.1371/journal.pone.0186475
Goulabchand, R. et al. Hospitalization risks for neurological disorders in primary Sjögren’s syndrome patients. J. Clin. Med. 11, 1979 (2022).
pubmed: 35407586
pmcid: 9000167
doi: 10.3390/jcm11071979
Hou, T.-Y. et al. Higher risk of dementia in primary Sjogren’s syndrome. Ann. Clin. Transl. Neurol. 6, 633–641 (2019).
pubmed: 31019988
pmcid: 6469245
doi: 10.1002/acn3.737
Pego-Reigosa, J. M., Restrepo Vélez, J., Baldini, C., Fernández, R.-F. & de Larrinoa, Í. Comorbidities (excluding lymphoma) in Sjögren’s syndrome. Rheumatology (Oxford) 60, 2075–2084 (2021).
doi: 10.1093/rheumatology/key329
Manzo, C., Serra-Mestres, J. & Isetta, M. Comment on: Comorbidities (excluding lymphoma) in Sjögren’s syndrome. Rheumatology https://doi.org/10.1093/rheumatology/keab602 (2021).
doi: 10.1093/rheumatology/keab602
pubmed: 34819707
pmcid: 8768041
Segal, B. et al. Primary Sjögren’s Syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes 7, 46 (2009).
pubmed: 19473510
pmcid: 2693523
doi: 10.1186/1477-7525-7-46
Liu, Z. et al. Health-related quality of life and psychological status of women with primary Sjögren’s syndrome: A cross-sectional study of 304 Chinese patients. Medicine (Baltimore) 96, e9208 (2017).
doi: 10.1097/MD.0000000000009208
Cui, Y. et al. Anxiety and depression in primary Sjögren’s syndrome: a cross-sectional study. BMC Psychiatr. 18, 1–8 (2018).
doi: 10.1186/s12888-018-1715-x
Hsieh, M.-C., Hsu, C.-W., Lu, M.-C. & Koo, M. Increased risks of psychiatric disorders in patients with primary Sjögren’s syndrome-a secondary cohort analysis of nationwide, population-based health claim data. Clin. Rheumatol. 38, 3195–3203 (2019).
pubmed: 31372849
doi: 10.1007/s10067-019-04705-z
Azarfar, A., Ahmed, A. & Bég, S. Prevalence of anxiety, depression, sleep disturbance, fibromyalgia, obesity, and gastroesophageal disease in patients with rheumatic diseases. Curr. Rheumatol. Rev. https://doi.org/10.2174/1573397116666201211124815 (2020).
doi: 10.2174/1573397116666201211124815
Segal, B. et al. Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren’s syndrome. Arthritis Rheum. 59, 1780–1787 (2008).
pubmed: 19035421
pmcid: 3106978
doi: 10.1002/art.24311
Karageorgas, T. et al. Fatigue in primary Sjögren’s syndrome: Clinical, laboratory, psychometric, and biologic associations. Arthritis Care Res. (Hoboken) 68, 123–131 (2016).
doi: 10.1002/acr.22720
Dardin, L. P. et al. Correlation of sleep quality with fatigue and disease activity among patients with primary Sjögren’s syndrome: A cross-sectional study. Sao Paulo Med. J. 138, 146–151 (2020).
pubmed: 32159602
doi: 10.1590/1516-3180.2019.0251.r1.1912019
Cui, Y. et al. Prevalence, correlates, and impact of sleep disturbance in Chinese patients with primary Sjögren’s syndrome. Int. J. Rheum. Dis. 23, 367–373 (2020).
pubmed: 31763772
doi: 10.1111/1756-185X.13678
Usmani, Z. A. et al. Sleep disordered breathing in patients with primary Sjögren’s syndrome: A group controlled study. Sleep Med. 13, 1066–1070 (2012).
pubmed: 22841036
doi: 10.1016/j.sleep.2012.06.010
Davies, K. et al. Fatigue in primary Sjögren’s syndrome (pSS) is associated with lower levels of proinflammatory cytokines: A validation study. Rheumatol. Int. 39, 1867–1873 (2019).
pubmed: 31250166
pmcid: 6791914
doi: 10.1007/s00296-019-04354-0
Howard Tripp, N. et al. Fatigue in primary Sjögren’s syndrome is associated with lower levels of proinflammatory cytokines. RMD Open 2, e000282 (2016).
pubmed: 27493792
pmcid: 4964201
doi: 10.1136/rmdopen-2016-000282
Omdal, R., Mellgren, S. I. & Norheim, K. B. Pain and fatigue in primary Sjögren’s syndrome. Rheumatology (Oxford) https://doi.org/10.1093/rheumatology/kez027 (2019).
doi: 10.1093/rheumatology/kez027
Mekinian, A. et al. Primary Sjögren’s syndrome: Central and peripheral nervous system involvements. Clin. Exp. Rheumatol. 38(Suppl 126), 103–109 (2020).
pubmed: 33095149
Fauchais, A.-L., Magy, L. & Vidal, E. Central and peripheral neurological complications of primary Sjögren’s syndrome. Presse Med. 41, e485-493 (2012).
pubmed: 22840992
doi: 10.1016/j.lpm.2012.06.002
de Oliveira, F. R. et al. Neurological and inflammatory manifestations in Sjögren’s syndrome: The role of the Kynurenine metabolic pathway. Int. J. Mol. Sci. 19, 3953 (2018).
pmcid: 6321004
doi: 10.3390/ijms19123953
Del Papa, N. et al. The role of interferons in the pathogenesis of Sjögren’s syndrome and future therapeutic perspectives. Biomolecules 11, 251 (2021).
pubmed: 33572487
pmcid: 7916411
doi: 10.3390/biom11020251
Tjensvoll, A. B. et al. Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren’s syndrome. J. Neurol. https://doi.org/10.1007/s00415-020-10290-y (2020).
doi: 10.1007/s00415-020-10290-y
pubmed: 33128084
pmcid: 7990817
Zhang, X.-D. et al. Altered hippocampal functional connectivity in primary Sjögren syndrome: A resting-state fMRI study. Lupus 29, 446–454 (2020).
pubmed: 32075510
doi: 10.1177/0961203320908936
Lauvsnes, M. B. et al. Loss of cerebral white matter in primary Sjögren’s syndrome: A controlled volumetric magnetic resonance imaging study. Eur. J. Neurol. 21, 1324–1329 (2014).
pubmed: 24943133
doi: 10.1111/ene.12486
Le Guern, V. et al. Cognitive function and 99mTc-ECD brain SPECT are significantly correlated in patients with primary Sjogren syndrome: a Case-control study. Ann. Rheum. Dis. 69, 132–137 (2010).
pubmed: 19158115
doi: 10.1136/ard.2008.090811
Miyamoto, S. T., Valim, V. & Fisher, B. A. Health-related quality of life and costs in Sjögren’s syndrome. Rheumatology (Oxford) https://doi.org/10.1093/rheumatology/key370 (2019).
doi: 10.1093/rheumatology/key370
Cornec, D. et al. Severe health-related quality of life impairment in active primary Sjögren’s syndrome and patient-reported outcomes: Data from a large therapeutic trial. Arthritis Care Res (Hoboken) 69, 528–535 (2017).
doi: 10.1002/acr.22974
Cui, Y. et al. The impact of disease activity and psychological status on quality of life for Chinese patients with primary Sjögren’s syndrome. Patient Prefer. Adherence 12, 1513–1519 (2018).
pubmed: 30174416
pmcid: 6110269
doi: 10.2147/PPA.S163417
Alunno, A. et al. Discrepancy between subjective symptoms, objective measures and disease activity indexes: The lesson of primary Sjögren’s syndrome. Clin. Exp. Rheumatol. 36(Suppl 112), 210–214 (2018).
pubmed: 30156545
Mæland, E., Miyamoto, S. T., Hammenfors, D., Valim, V. & Jonsson, M. V. Understanding fatigue in Sjögren’s syndrome: Outcome measures biomarkers and possible interventions. Front. Immunol. 12, 703079 (2021).
pubmed: 34249008
pmcid: 8267792
doi: 10.3389/fimmu.2021.703079
Bender, R. & Lange, S. Adjusting for multiple testing–when and how?. J. Clin. Epidemiol. 54, 343–349 (2001).
pubmed: 11297884
doi: 10.1016/S0895-4356(00)00314-0
Segal, B. M., Rhodus, N., Moser Sivils, K. L. & Solid, C. A. Validation of the brief cognitive symptoms index in Sjögren syndrome. J. Rheumatol. 41, 2027–2033 (2014).
pubmed: 25225280
doi: 10.3899/jrheum.140362